the molecular chaperone grp78/bip in the development of chemoresistance: mechanism and possible treatment
Clicks: 264
ID: 221423
2013
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
78.4
/100
263 views
212 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Treatment of several types of cancer such as lung, breast, prostate and pancreas has shown notable progresses in the past decades. However, after an initial response, tumors eventually became resistant to chemotherapy. This phenomenon, known as chemoresistance, accounts for the death of most cancer patients. Several studies in patients refractory to therapy have revealed the upregulation of the molecular chaperone GRP78/BiP both at the RNA and protein expression level. Furthermore GRP78/BiP relocates to the cell membrane in malignant but not in benign cells. In this communication we review studies on the role and the mechanism of action of GRP78/BiP during development of chemoresistance in cancer cells. In addition we discuss the possible role of GRP78 as a biomarker and as a target in cancer therapy.
| Reference Key |
eroller2013frontiersthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Corinna eRoller;Danilo eMaddalo |
| Journal | chemical research in chinese universities |
| Year | 2013 |
| DOI |
10.3389/fphar.2013.00010
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.